{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T21:30:53Z","timestamp":1770413453959,"version":"3.49.0"},"reference-count":41,"publisher":"American Society for Microbiology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2011,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The Centers for Disease Control and Prevention currently recommends a 2-tier serologic approach to Lyme disease laboratory diagnosis, comprised of an initial serum enzyme immunoassay (EIA) for antibody to<jats:named-content content-type=\"genus-species\">Borrelia burgdorferi<\/jats:named-content>followed by supplementary IgG and IgM Western blotting of EIA-positive or -equivocal samples. Western blot accuracy is limited by subjective interpretation of weakly positive bands, false-positive IgM immunoblots, and low sensitivity for detection of early disease. We developed an objective alternative second-tier immunoassay using a multiplex microsphere system that measures VlsE1-IgG and pepC10-IgM antibodies simultaneously in the same sample. Our study population comprised 79 patients with early acute Lyme disease, 82 patients with early-convalescent-phase disease, 47 patients with stage II and III disease, 34 patients post-antibiotic treatment, and 794 controls. A bioinformatic technique called partial receiver-operator characteristic (ROC) regression was used to combine individual antibody levels into a single diagnostic score with a single cutoff; this technique enhances test performance when a high specificity is required (e.g., \u226595%). Compared to Western blotting, the multiplex assay was equally specific (95.6%) but 20.7% more sensitive for early-convalescent-phase disease (89.0% versus 68.3%, respectively; 95% confidence interval [95% CI] for difference, 12.1% to 30.9%) and 12.5% more sensitive overall (75.0% versus 62.5%, respectively; 95% CI for difference, 8.1% to 17.1%). As a second-tier test, a multiplex assay for VlsE1-IgG and pepC10-IgM antibodies performed as well as or better than Western blotting for Lyme disease diagnosis. Prospective validation studies appear to be warranted.<\/jats:p>","DOI":"10.1128\/cvi.00409-10","type":"journal-article","created":{"date-parts":[[2011,3,3]],"date-time":"2011-03-03T03:26:21Z","timestamp":1299122781000},"page":"851-859","source":"Crossref","is-referenced-by-count":54,"title":["Multiplex Immunoassay for Lyme Disease Using VlsE1-IgG and pepC10-IgM Antibodies: Improving Test Performance through Bioinformatics"],"prefix":"10.1128","volume":"18","author":[{"given":"Richard B.","family":"Porwancher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Greg","family":"Hagerty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianqing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Landsberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara J. B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Kopnitsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen C.","family":"Steere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Kulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan J.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","published-online":{"date-parts":[[2011,3,2]]},"reference":[{"key":"key20180919073514_B1","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/CMR.18.3.484-509.2005","article-title":"Diagnosis of lyme borreliosis","volume":"18","author":"Aguero-Rosenfeld","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"key20180919073514_B2","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1086\/374395","article-title":"Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates","volume":"187","author":"Bacon","year":"2003","journal-title":"J. Infect. Dis."},{"key":"key20180919073514_B3","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1128\/IAI.00048-08","article-title":"A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi","volume":"76","author":"Barbour","year":"2008","journal-title":"Infect. Immun."},{"key":"key20180919073514_B4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/(SICI)1097-0258(20000315)19:5<649::AID-SIM371>3.0.CO;2-H","article-title":"Comparing diagnostic tests: a simple graphic using likelihood ratios","volume":"19","author":"Biggerstaff","year":"2000","journal-title":"Stat. Med."},{"key":"key20180919073514_B5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1086\/648674","article-title":"2-Tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test","volume":"50","author":"Branda","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"key20180919073514_B6","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1128\/CVI.00476-09","article-title":"Rapid, simple, quantitative, and highly sensitive antibody detection for Lyme disease","volume":"17","author":"Burbelo","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"issue":"RR-10","key":"key20180919073514_B7","first-page":"14","article-title":"Case definitions for infectious conditions under public health surveillance","volume":"46","author":"CDC","year":"1997","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"RR-13","key":"key20180919073514_B8","first-page":"19","article-title":"Case definitions for public health surveillance","volume":"39","author":"CDC","year":"1990","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"key20180919073514_B9","first-page":"590","article-title":"Recommendations for test performance and interpretation from the second National Conference on Serologic Diagnosis of Lyme Disease","volume":"44","author":"CDC","year":"1995","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"key20180919073514_B10","first-page":"36","article-title":"Summary of notifiable diseases\u2014United States, 2008","volume":"57","author":"CDC","year":"2010","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"key20180919073514_B11","author":"CDC\/ASTPHLD","year":"1994"},{"key":"key20180919073514_B12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/CVI.00461-10","article-title":"BBK07 immunodominant peptides as serodiagnostic markers of Lyme disease","volume":"18","author":"Coleman","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073514_B13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-0463.2010.02594.x","article-title":"Simultaneous use of serum IgG and IgM for risk scoring of suspected early Lyme borreliosis: graphical and bivariate analyses","volume":"118","author":"Dessau","year":"2010","journal-title":"APMIS"},{"key":"key20180919073514_B14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/1541-0420.00071","article-title":"Partial AUC estimation and regression","volume":"59","author":"Dodd","year":"2003","journal-title":"Biometrics"},{"key":"key20180919073514_B15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/infdis\/167.2.392","article-title":"Western blotting in the serodiagnosis of Lyme disease","volume":"167","author":"Dressler","year":"1993","journal-title":"J. Infect. Dis."},{"key":"key20180919073514_B16","article-title":"An introduction to the bootstrap","author":"Efron","year":"1995"},{"key":"key20180919073514_B17","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1128\/CVI.00075-07","article-title":"Dominant epitopes of the C6 diagnostic peptide of Borrelia burgdorferi are largely inaccessible to antibody on the parent VlsE molecule","volume":"14","author":"Embers","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073514_B18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/JCM.33.2.419-427.1995","article-title":"Immunoblot interpretation criteria for serodiagnosis of early Lyme disease","volume":"33","author":"Engstrom","year":"1995","journal-title":"J. Clin. Microbiol."},{"key":"key20180919073514_B19","unstructured":"Food and Drug Administration. 2010. In vitro diagnostics. Food and Drug Administration, Silver Spring, MD. http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfivd\/index.cfm. Accessed 10 August 2010."},{"key":"key20180919073514_B20","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/clinchem\/43.9.1749","article-title":"Advanced multiplexed analysis with the FlowMetrix system","volume":"43","author":"Fulton","year":"1997","journal-title":"Clin. Chem."},{"key":"key20180919073514_B21","doi-asserted-by":"crossref","DOI":"10.1128\/9781555816490","volume-title":"Tick-borne diseases of humans","author":"Goodman","year":"2005"},{"key":"key20180919073514_B22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0304-4076(87)90030-3","article-title":"Non-parametric analysis of a generalized regression model","volume":"35","author":"Han","year":"1987","journal-title":"J. Econom."},{"key":"key20180919073514_B23","first-page":"205","article-title":"Decision support for diagnosis of Lyme disease. Stud. Health Technol","volume":"116","author":"Hejlesen","year":"2005","journal-title":"Inform."},{"key":"key20180919073514_B24","first-page":"147","article-title":"Criteria for evaluation of immunoblots using Borrelia afzelii, Borrelia garinii and Borrelia burgdorferi sensu stricto for diagnosis of Lyme borreliosis","volume":"50","author":"Honegr","year":"2001","journal-title":"Epidemiol. Mikrobiol. Imunol."},{"key":"key20180919073514_B25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/infdis\/174.2.346","article-title":"Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting","volume":"174","author":"Johnson","year":"1996","journal-title":"J. Infect. Dis."},{"key":"key20180919073514_B26","article-title":"Gradient LASSO for feature selection","author":"Kim","journal-title":"Proceedings of the 21st International Conference on Machine Learning, Banff, Canada"},{"key":"key20180919073514_B27","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1128\/JCM.37.12.3997-4004.1999","article-title":"Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi","volume":"37","author":"Lawrenz","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"key20180919073514_B28","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1128\/JCM.37.12.3990-3996.1999","article-title":"Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE","volume":"37","author":"Liang","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"key20180919073514_B29","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1093\/bioinformatics\/bti724","article-title":"Regularized ROC method for disease classification and biomarker selection with microarray data","volume":"21","author":"Ma","year":"2005","journal-title":"Bioinformatics"},{"key":"key20180919073514_B30","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198509844.001.0001","article-title":"The statistical evaluation of medical tests for classification and prediction","author":"Pepe","year":"2003"},{"key":"key20180919073514_B31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1541-0420.2005.00420.x","article-title":"Combining predictors for classification using the area under the receiver operating characteristic curve","volume":"62","author":"Pepe","year":"2006","journal-title":"Biometrics"},{"key":"key20180919073514_B32","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/jnci\/djn326","article-title":"Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design","volume":"100","author":"Pepe","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"key20180919073514_B33","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1128\/JCM.41.11.4955-4960.2003","article-title":"C6 test as an indicator of therapy outcome for patients with localized or disseminated Lyme borreliosis","volume":"41","author":"Philipp","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"key20180919073514_B34","article-title":"Bioinformatic approach to disease diagnosis","volume-title":"Publication no. US20080064118","author":"Porwancher","year":"2008"},{"key":"key20180919073514_B35","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1128\/JCM.41.6.2791.2003","article-title":"Improving the specificity of recombinant immunoassays for Lyme disease","volume":"41","author":"Porwancher","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"key20180919073514_B36","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1086\/314651","article-title":"A reanalysis of IgM Western blot criteria for the diagnosis of early Lyme disease","volume":"179","author":"Porwancher","year":"1999","journal-title":"J. Infect. Dis."},{"key":"key20180919073514_B37","volume-title":"Lyme disease","author":"Rahn","year":"1998"},{"key":"key20180919073514_B38","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7326\/0003-4819-128-5-199803010-00003","article-title":"The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study","volume":"128","author":"Reid","year":"1998","journal-title":"Ann. Intern. Med."},{"key":"key20180919073514_B39","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1016\/B978-0-443-06839-3.00242-3","article-title":"Borrelia burgdorferi (Lyme disease, Lyme borreliosis)","volume":"vol. 2.","author":"Steere","year":"2010","journal-title":"Bennett's principles and practice of infectious diseases"},{"key":"key20180919073514_B40","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/589242","article-title":"Prospective study of serologic tests for Lyme disease","volume":"47","author":"Steere","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"key20180919073514_B41","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/376914","article-title":"Asymptomatic infection with Borrelia burgdorferi","volume":"37","author":"Steere","year":"2003","journal-title":"Clin. Infect. Dis."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.00409-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T18:23:02Z","timestamp":1712254982000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00409-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,2]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2011,5,3]]},"published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.1128\/CVI.00409-10"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00409-10","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,2]]}}}